Hospital Enterococcus faecium demonstrates distinct environmental and patient reservoirs: a genomic point prevalence survey

Introduction

Enterococcus faecium is a common cause of hospital-acquired infections and is frequently associated with vancomycin resistance [1], resulting in high mortality, longer hospital stays and higher healthcare costs [2]. The hospital environment is a reservoir for E. faecium due to its ability to survive on surfaces for prolonged periods [1]. Prior studies have analysed patient and environmental reservoirs of E. faecium but have typically been limited to selected hospital wards in settings where either vanA or vanB vancomycin-resistant E. faecium (VREfm) predominate [3-5]. Australia has a specific VREfm epidemiology with more recent emergence of vanA VREfm on a background of vanB VREfm endemicity, with both continuing to circulate [6]. In 2019, we noted increasing prevalence of vanA VREfm bloodstream infections. We aimed to assess the hospital environment as a reservoir of vanA VREfm by conducting a point prevalence study and comparing environmental and contemporary clinical isolates using genomic analyses.

Methods

The study was approved by the Alfred Hospital Ethics Committee. The Alfred Hospital (Melbourne, Australia) is a 600-bed quaternary hospital with state referral services for burns and trauma, as well as stem cell and solid organ (heart/lung/kidney) transplant services. We conducted a point prevalence survey of the hospital environment. We sampled surfaces using FLOQswabs (Copan) over two months, which included all wards and the intensive care unit (ICU) (n=12), with 10 surface types sampled per ward/ICU. Samples were cultured on CHROMagar VRE media (Biomerieux) and species were identified using matrix-assisted laser desorption-ionisation time-of-flight (MALDI-TOF) (Bruker Daltonics). To assess for molecular epidemiological links between environmental and clinical isolates, we selected all E. faecium blood culture isolates from our established biobank from 6 months prior to 6 months post the environmental sampling (Supp. Figure 1 and Supp. Table 1). Clinical data were extracted from the electronic medical record.

All E. faecium isolates underwent short-read (Illumina) whole genome sequencing, as described previously [7]. We detected van operon presence and assigned multi-locus sequence type (MLST) and core genome MLST (cgMLST) [8]. For each cgMLST cluster, we assembled a long-read reference genome and calculated within-cluster pairwise single nucleotide variant (SNV) distances. Please see Supplementary Methods for full details.

Results

Environmental point prevalence survey

We swabbed 357 surfaces (median 31.5 per ward [range 10-60]). A total of 73/357 (20%) surfaces isolated E. faecium, with median 20% positive per ward (IQR 11.6-30.6%) (Fig. 1A), indicating that E. faecium was endemic in the hospital environment. Rates of E. faecium positivity varied widely, with the highest rate in the Burns ward (10/10 swabs positive) and the lowest rate on Surgical Ward 3 (0/34 positive). Patient chairs had the highest rate of E. faecium positivity (13/25 [52%]) (Fig. 1B).

• Download figure
• Open in new tab

Figure 1 Summary of Enterococcus faecium environmental screening and contemporary clinical isolates

A) Proportion of environmental screening swabs positive for E. faecium by ward and B) by surface type. C) Summary of E. faecium van operon presence by multi-locus sequence types (MLST) and D) core genome MLST (cgMLST) in clinical and environmental isolates.

E. faecium transmission networks

Using a 6 SNV cutoff [4], there were 895 putative genomic transmission links resulting in 13 clusters (Fig. 2). While 292/895 (33%) links were environmental-clinical, of these only 88/292 (30%) were between vanA genomes. Most clusters had a predominance of either environmental-environmental links or clinical-clinical links (Supp. Table 2). A single cluster contained 25/44 (57%) vanA genomes, with the majority being clinical (22/26, 85%). Environmental genomes in that cluster came from three wards, while clinical genomes came from 11 wards. In contrast, vanB genomes belonged to three major (>5 genomes) clusters, containing predominantly environmental genomes (42/56, 75%).

• Download figure
• Open in new tab

Figure 2 Network analysis of Enterococcus faecium putative genomic transmission links

Clinical and environmental E. faecium genomes are shown as nodes and putative genomic transmission events (defined as pairwise single nucleotide variant distance <6) as edges. Edges resulting from clinical-environmental links are shown in black, and clinical-clinical or environmental-environmental in grey. A single major vanA cluster is noted with majority of clinical genomes. In contrast, three major vanB clusters are noted with environmental genomes predominating.

Discussion

We noted a 20% prevalence of E. faecium environmental colonisation across a diverse range of hospital surfaces, but only 12/73 (17%) environmental genomes carried vanA. This indicated that while E. faecium was endemic in the hospital environment, it likely did not make a major contribution to the increased vanA VREfm prevalence in bloodstream infection isolates. Indeed, we noted distinct environmental and patient reservoirs: an environment dominated by vanB ST796/78 genomes, and a clinical reservoir comprising vanA ST1421/1424 genomes. There was evidence of spill-over with putative clinical-environmental links, but these were a minority (33%) and vanA putative genomic links only contributed 88/895 (10%) of these in turn.

Our findings stand in contrast to prior work showing significant links between VREfm in the environment and clinical colonisation and infection [3-5]. This difference may be due to these studies describing non-outbreak settings and focusing on limited wards (ICU and Haematology/Oncology). Potential contributors to our findings include our institution’s differing infection prevention approaches to vanA and vanB VREfm-colonised patients [9]: vanA patients are routinely placed in contact precautions, while for vanB patients this occurs only on high-risk wards and if they have diarrhoea or non-contained wounds. E. faecium ST796, a key vanB lineage in our study, has been shown to develop biocide tolerance that may provide it with a fitness advantage in hospital environments [10]. Of note, the vanA clinical reservoir that prompted our investigation subsequently resolved during the COVID-19 pandemic (Supp. Fig. 1), perhaps because of these factors.

Although the environment plays a major role in healthcare-associated VREfm spread, our study shows that distinct clinical and environmental reservoirs of VREfm may exist, particularly in outbreak settings where new clones are emerging and have not yet colonised the environment. This provides support for use of molecular techniques to focus infection prevention strategies according to the reservoir. While cleaning strategies aiming to reduce the environmental burden form an essential part of any multifaceted approach to VREfm control [11], the clinical reservoir may require more active attention through measures such as introduction of active surveillance, redoubled hand hygiene efforts and more stringent application of contact precautions in order to prevent both between-patient spread and future environmental colonisation.

Conflict of Interest Statements

Nil relevant.

Role of Funding Source

This work was supported by the National Health and Medical Research Council of Australia (Emerging Leader 1 Fellowship APP1176324 to N.M., Practitioner Fellowship APP1117940 to A.Y.P.).

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Conference Presentation

Portions of this work were presented at European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global 2024, held in Barcelona, Spain.